Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/12/2010US20100203039 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
08/12/2010US20100203038 Methods of using gpr119 to identify compounds useful for increasing bone mass in an individual
08/12/2010US20100203037 identifying a Glucose-dependent Insulinotropic Peptide (GIP) secretagogue; G protein-coupled receptor (GPCR); useful as therapeutic agents for treating or preventing a condition characterized by low bone mass, such as osteoporosis
08/12/2010US20100203036 Targets for tumor growth inhibition
08/12/2010US20100203035 B7-h3 in cancer
08/12/2010US20100203032 Orlistat compositions
08/12/2010US20100203031 Method for enhancing the cleavage activity of i-crei derived meganucleases
08/12/2010US20100203027 Viral vector for gene therapy
08/12/2010US20100203020 Methods of generating, repairing and/or maintaining connective tissue in vivo
08/12/2010US20100203017 Cladribine Regimen for Treating Multiple Sclerosis
08/12/2010US20100203016 Pregnancy hormone combination for treatment of autoimmune diseases
08/12/2010US20100203015 Carba-nucleoside analogs for antiviral treatment
08/12/2010US20100203013 Treating Hepatitis C Virus Infection
08/12/2010US20100203012 Iap bir domain binding compounds
08/12/2010US20100203009 Pathway for Th-17 Cell Development and Methods Utilizing Same
08/12/2010US20100203007 Novel benzodiazepine derivatives
08/12/2010US20100203006 Devolatilization apparatus and process
08/12/2010US20100203005 Transdermal compositions
08/12/2010US20100203004 Cosmetic composition containing a tensioning agent and an acrylic polymer
08/12/2010US20100203001 Process for forming disulfide bridges
08/12/2010US20100202989 Methods for treatment of dermatological conditions
08/12/2010US20100202986 Compositions For Delivering A Drug
08/12/2010US20100202984 Naphthalene amidine imides
08/12/2010US20100202979 Compositions and methods for treatment of pulmonary diseases and conditions
08/12/2010US20100202977 Modulation of Stat 6 Expression for the Treatment of Airway Hyperresponsiveness
08/12/2010US20100202973 Microrna molecules associated with inflammatory skin disorders
08/12/2010US20100202971 Compound having tumor-resident property
08/12/2010US20100202969 Nanoparticles for imaging and treating chlamydial infection
08/12/2010US20100202968 Method of Providing Disease-Specific Binding Molecules and Targets
08/12/2010US20100202963 Therapies for hematologic malignancies
08/12/2010US20100200066 Methods and intermediates for the synthesis of dipyrrin-substituted porphyrinic macrocycles
08/12/2010DE102009008256A1 Prodrugs vom Typ N-hydroxylierter Amidine, Guanidine und/oder Aminohydrazone zur Applikation über die Haut Prodrugs of type N-hydroxylated amidines, guanidines and / or Aminohydrazone for application on the skin
08/12/2010DE102009007997A1 New nitrogen-containing compounds useful e.g. as a repellent for resistance and/or deterrence of arthropods e.g. mosquitoes, horseflies fleas, lice, ticks, mites and ants in cosmetic and/or dermatological formulations
08/12/2010DE102009007929A1 Use of L-ribozymes (which are capable of splitting L-RNA in a region of a target sequence) for preparing composition to treat undesired physiological secondary reactions due to administration of a therapeutic molecule containing L-RNA
08/12/2010DE102009007853A1 Mit Alkylphosphocholinen behandelte Intraokularlinsen zur pharmakologischen Nachstarprophylaxe Treated with alkylphosphocholines intraocular lenses for the pharmacological Nachstarprophylaxe
08/12/2010CA2761389A1 Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens
08/12/2010CA2751987A1 Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
08/12/2010CA2751695A1 Aminopyrazine derivatives and medicines
08/12/2010CA2751638A1 Medicinal use of 5-benzylaminosalicylic acid derivative or its salt
08/12/2010CA2751565A1 Pyridazinone compounds
08/12/2010CA2751563A1 Methods of inhibiting fibrogenesis and treating fibrotic disease
08/12/2010CA2751539A1 Derivatives of 6-(6-nh-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010CA2751536A1 Indoline derivatives
08/12/2010CA2751535A1 Substituted spiro-amides as b1r modulators
08/12/2010CA2751525A1 Derivatives of 6-(6-o-cycloalkyl or 6-nh-cycloalkyl-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010CA2751495A1 Pharmaceutical compositions comprising a pyridyl cyanoguanidine and cyclodextrin and/or derivatives thereof
08/12/2010CA2751494A1 Benzoic acid (1-phenyl-2-pyridin-4-yl) ethyl esters as phosphodiesterase inhibitors
08/12/2010CA2751489A1 Dual targeting of mir-208 and mir-499 in the treatment of cardiac disorders
08/12/2010CA2751481A1 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
08/12/2010CA2751474A1 Derivatives of 6-(6-substituted-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles and 5-fluoro-benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as metinhibitors
08/12/2010CA2751458A1 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
08/12/2010CA2751443A1 Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma
08/12/2010CA2751412A1 Methods of reducing the proliferation and viability of microbial agents
08/12/2010CA2751402A1 Substituted indole compounds as bradykinin receptor 1 modulators
08/12/2010CA2751399A1 Buccal application system comprising 17a-estradiol
08/12/2010CA2751397A1 Treatment of lung cancer with a parp inhibitor in combination with a growth factor inhibitor
08/12/2010CA2751392A1 Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
08/12/2010CA2751386A1 Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
08/12/2010CA2751313A1 Process for the preparation of a pharmaceutical composition comprising ezetimibe
08/12/2010CA2751304A1 Hesperidin-containing composition
08/12/2010CA2751270A1 Pharmaceutical grade phthalazinediones, process for their preparation and pharmaceutical compositions containing them
08/12/2010CA2751263A1 Novel saponin compounds, methods of preparation thereof, use thereof and pharmaceutical compositions
08/12/2010CA2751141A1 Inhibitors of jun n-terminal kinase
08/12/2010CA2751039A1 Pharmaceutical composition for oral administration
08/12/2010CA2750935A1 Heteroaryls and their use as pi3k inhibitors
08/12/2010CA2750875A1 Derivatives of 6-(6-o-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010CA2750844A1 Triptolide c-ring derivatives as anticancer agents and immune modulators
08/12/2010CA2750714A1 Dihydroquinolinone derivatives
08/12/2010CA2750704A1 Phenylimidazole compounds
08/12/2010CA2750611A1 Chronotherapeutic pharmaceutical composition
08/12/2010CA2750519A1 Novel benzodiazepine derivatives
08/12/2010CA2750517A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
08/12/2010CA2750089A1 Novel method for the synthesis of ivabradine and the pharmaceutically acceptable acid addition salts thereof
08/12/2010CA2749933A1 Formulations of desvenlafaxine
08/12/2010CA2749856A1 Isoxazole-3-carboxamide derivatives
08/12/2010CA2749837A1 Derivatives of n2-(3-pyridil or phenyl) -n4- (4-piperidyl) -2,4- pyrimidinediamine useful in the treatment of inflammatory, autoimmune or proliferative diseases
08/12/2010CA2749677A1 Isoxazole-5-carboxamide derivatives
08/12/2010CA2749358A1 A novel cyanopyrimidine derivative
08/12/2010CA2749309A1 Pyrrolidine triple reuptake inhibitors
08/12/2010CA2749209A1 Indole derivatives as anticancer agents
08/12/2010CA2748943A1 Pyrrolopyrimidinyl axl kinase inhibitors
08/12/2010CA2748862A1 Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
08/12/2010CA2744946A1 Cyclic inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
08/12/2010CA2741052A1 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
08/12/2010CA2724152A1 Solid state forms of aliskiren compounds
08/11/2010EP2216343A1 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
08/11/2010EP2216335A1 Tetriacyclodipyranyl coumarins and the anti-hiv and anti-tuberculosis uses thereof
08/11/2010EP2216334A1 Hiv protease inhibiting sulfonamides
08/11/2010EP2216330A1 Oxadiazolidinedione compound
08/11/2010EP2216329A1 Processes for the preparation of tadalafi
08/11/2010EP2216327A1 Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors
08/11/2010EP2216323A2 Methods for synthesizing and purifying aminoalkyl tetracycline compounds
08/11/2010EP2216319A2 Oligomers of straight-chain and unbranched fatty acids, and medicaments containing the same
08/11/2010EP2216318A2 Resolvins: Biotemplates for therapeutic interventions
08/11/2010EP2216073A1 Methods and compositions for treating diseases and conditions associated with mitochondrial function
08/11/2010EP2216047A1 Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient
08/11/2010EP2216037A1 Periodontal bacterial growth inhibitor, oral hygiene product, and food and drink
08/11/2010EP2216031A1 Buffered Compositions for dialysis
08/11/2010EP2216030A1 Prevention of in-stent thrombosis and complications after arterial angioplasty with stent placement using magnesium
08/11/2010EP2216029A2 Oligonucleotides for treatment of prostate and other cancers